16-74713907-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_024306.5(FA2H):​c.*283G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0313 in 432,770 control chromosomes in the GnomAD database, including 1,071 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.063 ( 842 hom., cov: 33)
Exomes 𝑓: 0.014 ( 229 hom. )

Consequence

FA2H
NM_024306.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.316

Publications

0 publications found
Variant links:
Genes affected
FA2H (HGNC:21197): (fatty acid 2-hydroxylase) This gene encodes a protein that catalyzes the synthesis of 2-hydroxysphingolipids, a subset of sphingolipids that contain 2-hydroxy fatty acids. Sphingolipids play roles in many cellular processes and their structural diversity arises from modification of the hydrophobic ceramide moiety, such as by 2-hydroxylation of the N-acyl chain, and the existence of many different head groups. Mutations in this gene have been associated with leukodystrophy dysmyelinating with spastic paraparesis with or without dystonia.[provided by RefSeq, Mar 2010]
FA2H Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 35
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 16-74713907-C-G is Benign according to our data. Variant chr16-74713907-C-G is described in ClinVar as [Benign]. Clinvar id is 320484.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.201 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FA2HNM_024306.5 linkc.*283G>C 3_prime_UTR_variant Exon 7 of 7 ENST00000219368.8 NP_077282.3 Q7L5A8-1
FA2HXM_011523319.3 linkc.*283G>C 3_prime_UTR_variant Exon 7 of 7 XP_011521621.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FA2HENST00000562145.1 linkn.1123G>C non_coding_transcript_exon_variant Exon 2 of 2 1
FA2HENST00000219368.8 linkc.*283G>C 3_prime_UTR_variant Exon 7 of 7 1 NM_024306.5 ENSP00000219368.3 Q7L5A8-1
FA2HENST00000567683.5 linkn.*681G>C non_coding_transcript_exon_variant Exon 5 of 5 2 ENSP00000455126.1 H3BP32
FA2HENST00000567683.5 linkn.*681G>C 3_prime_UTR_variant Exon 5 of 5 2 ENSP00000455126.1 H3BP32

Frequencies

GnomAD3 genomes
AF:
0.0626
AC:
9523
AN:
152098
Hom.:
842
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.205
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.0214
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.000387
Gnomad SAS
AF:
0.0143
Gnomad FIN
AF:
0.0167
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.00513
Gnomad OTH
AF:
0.0407
GnomAD4 exome
AF:
0.0142
AC:
3996
AN:
280554
Hom.:
229
Cov.:
0
AF XY:
0.0133
AC XY:
1918
AN XY:
144366
show subpopulations
African (AFR)
AF:
0.205
AC:
1957
AN:
9530
American (AMR)
AF:
0.0150
AC:
202
AN:
13422
Ashkenazi Jewish (ASJ)
AF:
0.00352
AC:
32
AN:
9084
East Asian (EAS)
AF:
0.00
AC:
0
AN:
21346
South Asian (SAS)
AF:
0.0133
AC:
289
AN:
21690
European-Finnish (FIN)
AF:
0.0163
AC:
291
AN:
17870
Middle Eastern (MID)
AF:
0.0253
AC:
32
AN:
1266
European-Non Finnish (NFE)
AF:
0.00499
AC:
844
AN:
169082
Other (OTH)
AF:
0.0202
AC:
349
AN:
17264
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
173
346
520
693
866
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0626
AC:
9532
AN:
152216
Hom.:
842
Cov.:
33
AF XY:
0.0608
AC XY:
4529
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.205
AC:
8504
AN:
41496
American (AMR)
AF:
0.0214
AC:
327
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00346
AC:
12
AN:
3472
East Asian (EAS)
AF:
0.000388
AC:
2
AN:
5156
South Asian (SAS)
AF:
0.0137
AC:
66
AN:
4822
European-Finnish (FIN)
AF:
0.0167
AC:
177
AN:
10620
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00513
AC:
349
AN:
68024
Other (OTH)
AF:
0.0402
AC:
85
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
412
824
1237
1649
2061
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00312
Hom.:
2
Bravo
AF:
0.0701
Asia WGS
AF:
0.0140
AC:
47
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 17, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia 35 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
4.3
DANN
Benign
0.61
PhyloP100
0.32
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs80215625; hg19: chr16-74747805; API